Clinical Trial Update: Effect of Paricalcitol Over Vessel Wall [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of paricalcitol on the vessel wall in nephropathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Effice Servicios Para la Investigacion S.L. | Conditions: Nephropathy | Phase 4 | Status: TERMINATED